Stay updated on Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial

Sign up to get notified when there's something new on the Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-01T15:09:35.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    A site-wide NIH notice was added explaining that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    0.9%
    Check dated 2026-10-25T15:44:09.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-18T15:54:10.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The displayed ClinicalTrials.gov revision changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T15:51:51.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The study history now includes a new revision v3.7.0 and removes the older v3.6.6 from the visible history, updating the record's version history.
    Difference
    0.1%
    Check dated 2026-09-20T20:07:35.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    A newer site revision tag (v3.6.6) has been added to the page, signaling an underlying platform update for the Record History view. This change does not modify the study data or how the history is displayed.
    Difference
    0.1%
    Check dated 2026-08-30T06:32:22.000Z thumbnail image

Stay in the know with updates to Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial page.